Search - tctmd.com

Displaying 641 - 660 of 671

Sort: Relevancy | Date

News Daily News

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Leah Lawrence

April 26, 2011

News Daily News

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

April 20, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

News Conference News

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

April 05, 2011

News Conference News

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

L.A. McKeown

April 05, 2011

News Conference News

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Caitlin E. Cox

April 04, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

April 04, 2011

News Conference News

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Jason Kahn

April 04, 2011

News Industry News

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

April 04, 2011

News Industry News

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

April 03, 2011

News Daily News

Vascular Stents an Option for Some Patients with Fibrosing Mediastinitis

March 29, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

News Daily News

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

March 21, 2011

News Daily News

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

Caitlin E. Cox

March 16, 2011

News Daily News

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

L.A. McKeown

March 15, 2011

News Daily News

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

March 14, 2011

News Daily News

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

L.A. McKeown

March 10, 2011

News Daily News

Studies Support DES Use in Diabetics, But Results Vary by Device

Caitlin E. Cox

March 08, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

Advertisement

Everolimus-Eluting Stents Found Equivalent to First-Generation Stents in Most Patients at 1 Year

Two-Year Data Published from SPIRIT IV, COMPARE: Xience Still Favored Over Taxus

Therapies Take on In-Stent Restenosis with Mixed Results

PRECOMBAT: PCI with Sirolimus Stent Equivalent to CABG in Left Main Disease

PLATINUM: Novel Platinum-Chromium DES Equals Outcomes of Xience V-Promus

RESOLUTE US Looks at Latest-Generation Zotarolimus Stent

Medtronic Resolute® Drug-Eluting Stent Delivers Compelling Clinical Outcomes in Major Studies

ISAR-CABG: DES Superior to BMS in Saphenous Vein Graft Lesions

Boston Scientific's Promus Element™ Platinum Chromium Stent System Demonstrates Comparable Safety And Effectiveness Outcomes Versus Leading Drug-Eluting Stent In Platinum Workhorse Trial

Analysis of Data Across Multiple Drug Eluting Stent Trials Reinforces Positive Clinical Performance of XIENCE V®

Vascular Stents an Option for Some Patients with Fibrosing Mediastinitis

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Stent Thrombosis, Major Bleeding Rare with Sirolimus-Eluting Stents

SYNTAX Analysis: PCI, CABG Offer Substantial Symptom Relief But Timing Differs

GRAVITAS Published: No Benefit from High-Dose Clopidogrel in Poor Responders

Restenosis After Left Main Stenting Does Not Affect Long-term Prognosis

IVUS Supports Effectiveness of Novel Stent with Bioabsorbable Polymer

Studies Support DES Use in Diabetics, But Results Vary by Device

Cilostazol Reduces Repeat Revascularizations for Long Lesions

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content